| Name | Title | Contact Details |
|---|
Ohr Pharmaceutical, Inc. (OHRP) is an ophthalmology research and development company. The company`s lead product, Squalamine (OHR-102), is currently being studied as an eye drop formulation in several company sponsored and investigator sponsored Phase II clinical trials for various back-of-the-eye diseases, including the wet form of age-related macular degeneration, retinal vein occlusion, diabetic macular edema, and proliferative diabetic retinopathy. In addition, Ohr has a sustained release micro fabricated micro-particle ocular drug delivery platform with several preclinical drug product candidates in development for glaucoma, steroid-induced glaucoma, ocular allergies, and protein drug delivery.
Great Lakes Drug Development is a Brighton, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Janssen-Ortho Inc. is a North York, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Bioxene is a Honolulu, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
encompass clinical research is a Spring Valley, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.